MFDS — authorised 7 December 2001
- Marketing authorisation holder: MYLAN IRELAND LTD
- Status: likely_approved
🇰🇷 Arixtra in South Korea
MFDS authorised Arixtra on 7 December 2001
Marketing authorisation
Arixtra in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in South Korea
Frequently asked questions
Is Arixtra approved in South Korea?
Yes. MFDS authorised it on 7 December 2001.
Who is the marketing authorisation holder for Arixtra in South Korea?
MYLAN IRELAND LTD holds the South Korean marketing authorisation.